227 related articles for article (PubMed ID: 15490426)
1. Adjusting the generalized ROC curve for covariates.
Schisterman EF; Faraggi D; Reiser B
Stat Med; 2004 Nov; 23(21):3319-31. PubMed ID: 15490426
[TBL] [Abstract][Full Text] [Related]
2. On linear combinations of biomarkers to improve diagnostic accuracy.
Liu A; Schisterman EF; Zhu Y
Stat Med; 2005 Jan; 24(1):37-47. PubMed ID: 15515132
[TBL] [Abstract][Full Text] [Related]
3. Confidence intervals for the generalized ROC criterion.
Reiser B; Faraggi D
Biometrics; 1997 Jun; 53(2):644-52. PubMed ID: 9235120
[TBL] [Abstract][Full Text] [Related]
4. ROC analysis for markers with mass at zero.
Schisterman EF; Reiser B; Faraggi D
Stat Med; 2006 Feb; 25(4):623-38. PubMed ID: 16345033
[TBL] [Abstract][Full Text] [Related]
5. Minimal and best linear combination of oxidative stress and antioxidant biomarkers to discriminate cardiovascular disease.
Schisterman EF; Faraggi D; Browne R; Freudenheim J; Dorn J; Muti P; Armstrong D; Reiser B; Trevisan M
Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):259-66. PubMed ID: 12616805
[TBL] [Abstract][Full Text] [Related]
6. Combining diagnostic test results to increase accuracy.
Pepe MS; Thompson ML
Biostatistics; 2000 Jun; 1(2):123-40. PubMed ID: 12933515
[TBL] [Abstract][Full Text] [Related]
7. Marker selection via maximizing the partial area under the ROC curve of linear risk scores.
Wang Z; Chang YC
Biostatistics; 2011 Apr; 12(2):369-85. PubMed ID: 20729218
[TBL] [Abstract][Full Text] [Related]
8. [Generalized ROC criteria in the evaluation of several tumor markers].
Kramar A; Faraggi D; Ychou M; Reiser B; Grenier J
Rev Epidemiol Sante Publique; 1999 Sep; 47(4):376-83. PubMed ID: 10519178
[TBL] [Abstract][Full Text] [Related]
9. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
Poynard T; Halfon P; Castera L; Charlotte F; Le Bail B; Munteanu M; Messous D; Ratziu V; Benhamou Y; Bourlière M; De Ledinghen V;
Aliment Pharmacol Ther; 2007 Mar; 25(6):733-9. PubMed ID: 17311607
[TBL] [Abstract][Full Text] [Related]
10. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.
Flamini E; Mercatali L; Nanni O; Calistri D; Nunziatini R; Zoli W; Rosetti P; Gardini N; Lattuneddu A; Verdecchia GM; Amadori D
Clin Cancer Res; 2006 Dec; 12(23):6985-8. PubMed ID: 17145818
[TBL] [Abstract][Full Text] [Related]
11. ROC methodology within a monitoring framework.
Parker CB; DeLong ER
Stat Med; 2003 Nov; 22(22):3473-88. PubMed ID: 14601014
[TBL] [Abstract][Full Text] [Related]
12. Evaluating diagnostic tests: The area under the ROC curve and the balance of errors.
Hand DJ
Stat Med; 2010 Jun; 29(14):1502-10. PubMed ID: 20087877
[TBL] [Abstract][Full Text] [Related]
13. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test.
Gengsheng Qin ; Hotilovac L
Stat Methods Med Res; 2008 Apr; 17(2):207-21. PubMed ID: 18426855
[TBL] [Abstract][Full Text] [Related]
14. The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Ostrowska J; Gralak B; Majchrzak J
Transplant Proc; 2006; 38(1):86-9. PubMed ID: 16504671
[TBL] [Abstract][Full Text] [Related]
15. Semi-parametric ROC regression analysis with placement values.
Cai T
Biostatistics; 2004 Jan; 5(1):45-60. PubMed ID: 14744827
[TBL] [Abstract][Full Text] [Related]
16. Semiparametric estimation of time-dependent ROC curves for longitudinal marker data.
Zheng Y; Heagerty PJ
Biostatistics; 2004 Oct; 5(4):615-32. PubMed ID: 15475423
[TBL] [Abstract][Full Text] [Related]
17. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers.
Zheng Y; Cai T; Feng Z
Biometrics; 2006 Mar; 62(1):279-87. PubMed ID: 16542256
[TBL] [Abstract][Full Text] [Related]
18. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part II: the use of ROC curves in the choice of electrocardiographic stress test markers of ischaemia.
Marazìa S; Barnabei L; De Caterina R
J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):22-31. PubMed ID: 18268415
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the area under the ROC curve.
Faraggi D; Reiser B
Stat Med; 2002 Oct; 21(20):3093-106. PubMed ID: 12369084
[TBL] [Abstract][Full Text] [Related]
20. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
